Through correlation analysis between SMC4 gene expression levels and TGFβ-related gene signatures, we predicted that SMC4 promotes glioma cell aggressiveness and activates the TGFβ/Smad pathway. This evidence concerns the gene SMC4 and central nervous system cancer.